Living at high altitude tied to developmental delay 
November 1st, 2012
By Genevra Pittman NEW YORK | Thu Nov 1, 2012 10:10am EDT NEW YORK (Reuters Health) – South American babies and toddlers living at high altitude were more likely to score poorly on early tests of brain development, in a new study. Of all kids age three months to two years, one in five was at high risk of developmental delays, according to tests done at their pediatricians’ offices
[Continue Reading...]
Women hoist kettlebells for strength and shapeliness
October 29th, 2012
By Dorene Internicola NEW YORK | Mon Oct 29, 2012 9:38am EDT NEW YORK (Reuters) – Kettlebells, classically a training tool of Russian strongmen, has become a go-to group fitness workout for women in pursuit of strong and sexy bodies, according to fitness experts. Lorna Kleidman, a world champion in kettlebell competition, said a modern kettlebell workout effectively combines cardiovascular, resistance and range-of-motion training, all in one hour. “It’s all in the swing,” said Kleidman, who teaches kettlebell classes at the Fitness Cell Collective in New York City, where women constitute up to 70 percent of her students.
[Continue Reading...]
Meds a good "first step" for treating alcoholism
October 26th, 2012
By Genevra Pittman NEW YORK | Fri Oct 26, 2012 10:16am EDT NEW YORK (Reuters Health) – Two drugs commonly used to treat alcoholism may be appropriate for people in different stages of recovery, a new analysis confirms – likely because they work differently in the brain. The drugs, acamprosate (marketed as Campral) and naltrexone (ReVia), are both non-addictive themselves and don’t make users sick when mixed with alcohol. So they’re a good first option for people struggling with alcohol dependence who are motivated to stop drinking but would like to avoid an inpatient program, researchers said
[Continue Reading...]
Meningitis outbreak spreads to 18 states with South Carolina case
October 25th, 2012
Tweet Share this Email Print A sample of Cladosporium species, one of the fungi diagnosed in the fungal meningitis outbreak sweeping the United States, in Nashville, Tennessee on October 19, 2012. Credit: Reuters/Harrison McClary Thu Oct 25, 2012 2:34pm EDT (Reuters) – The deadly outbreak of fungal meningitis tied to tainted steroid medications from a Massachusetts company expanded to 18 states on Thursday with South Carolina reporting its first probable case of the disease
[Continue Reading...]
Death toll from West Nile virus tops 200: government
October 24th, 2012
By Marice Richter DALLAS | Wed Oct 24, 2012 1:44pm EDT DALLAS (Reuters) – The U.S. outbreak of West Nile virus has killed 219 people this year, after another 36 deaths from the mosquito-borne disease were reported last week, government figures showed Wednesday
[Continue Reading...]
Alere gets FDA warning letter over San Diego facility
October 24th, 2012
Wed Oct 24, 2012 11:57am EDT (Reuters) – The Food and Drug Administration issued a warning letter to Alere Inc saying the diagnostic device maker’s response to the health regulator’s earlier observations on manufacturing processes for the company’s Triage products was not adequate.
[Continue Reading...]
Monster Beverage shares down more, analysts weigh views
October 23rd, 2012
1 of 2. Fourteen-year-old Anais Fournier is seen in this undated family handout photo taken in Hagerstown, Maryland. Monster Energy drink is being sued by the family of Fournier, who died after drinking two cans of Monster Energy drink in a 24-hour period
[Continue Reading...]
Medicine rarely a slam dunk, despite splashy studies
October 23rd, 2012
By Frederik Joelving NEW YORK | Tue Oct 23, 2012 4:31pm EDT NEW YORK (Reuters Health) – Next time a research finding leaves you slack-jawed, thinking it’s too good to be true, you might just be right, according to a massive new analysis tracking the fate of splashy medical studies. It turns out that 90 percent of the “very large” effects described in initial reports on medical treatments begin to shrink or vanish as more studies are done.
[Continue Reading...]
Counseling slows weight gain in obese moms-to-be
October 18th, 2012
By Kerry Grens NEW YORK | Thu Oct 18, 2012 11:48am EDT NEW YORK (Reuters Health) – Motivational counseling can slow down pregnancy weight gain in obese women and may take the edge off their anxiety, too, according to a new study from Belgium. It’s recommended that obese women gain no more than 11 to 20 pounds during pregnancy to avoid health complications in both baby and mother.
[Continue Reading...]
Analysis links psoriasis, diabetes
October 17th, 2012
By Genevra Pittman NEW YORK | Wed Oct 17, 2012 3:36pm EDT NEW YORK (Reuters Health) – A new review of more than two dozen studies adds support to the link between the chronic skin disease psoriasis and diabetes. In studies from the United States, Europe, the Middle East and elsewhere, participants with psoriasis had anywhere from an equal risk to an almost four-fold higher risk of developing diabetes than those without the skin condition
[Continue Reading...]
